EIT During FCV in the Intensive Care Unit
Launched by ERASMUS MEDICAL CENTER · Dec 1, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older;
- • Informed consent form signed by the subject or a legal representative;
- • Controlled mechanical ventilation via an endotracheal tube -
- • FiO2 ≤50% and PEEP 10 cmH2O or lower
- Exclusion Criteria:
- • Severe sputum stasis or production requiring frequent bronchial suctioning (more than 5 times per nurse shift)
- • Severe respiratory insufficiency defined as a PaO2 to FiO2 ratio of \<100mmHg or moderate to severe ARDS according to the Berlin definition of ARDS
- • Untreated pneumothorax (i.e. no pleural drainage)
- • Hemodynamic instability defined as a mean arterial pressure below 60mmHg not responding to fluids and/or vasopressors or a noradrenalin dose \>0.4mg/kg/min
- • Excessive subcutaneous emphysema (prevents proper functioning of the EIT device)
- • Thoracic wounds, bandages or other obstruction which prevent proper functioning of the EIT device
- • High (\>15 mmHg) or instable (an increase in sedation or osmotherapy is required) intracranial pressure
- • An inner tube diameter of 6mm or less
Trial Officials
Henrik Endeman, MD, PhD
Principal Investigator
Erasmus MC, Rotterdam
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, Zuid Holland, Netherlands
Rotterdam, South Holland, Netherlands
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials